1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer Version 5.2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (2022).
3. Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations;Paik;N Engl J Med,2020
4. Capmatinib in MET exon 14–mutated or MET -amplified non–small-cell lung cancer;Wolf;N Engl J Med,2020
5. Characterization of non-small-cell lung cancers with MET exon 14 skipping alterations detected in tissue or liquid: clinicogenomics and real-world treatment patterns;Lee;JCO Precis Oncol,2021